Skip to content

Nalbuphine combined with propofol for elderly painless gastrointestinal endoscopy: a randomized controlled study

Nalbuphine combined with propofol for elderly painless gastrointestinal endoscopy: a randomized controlled study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024920
Enrollment
Unknown
Registered
2019-08-03
Start date
2019-08-01
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System Disease

Interventions

1:Sufentanil + propofol
2:Nabrephine 0.1mg/kg+ propofol
3:Nabrephine 0.2mg/kg+ propofol
4:Nabrephine 0.3mg/kg+ propofol

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 65-80 years; 2. Body mass index (BMI):18~25 kg/m2; 3. American society of anesthesiologists (ASA) grade: I-II; 4. Patients who voluntarily underwent painless gastroenteroscopy and signed the informed consent;

Exclusion criteria

Exclusion criteria: 1. Hypertension > 180/110 mmHg or hypotension < 90/60 mmHg; 2. Long-term use of hormones and other immunosuppressive drugs; 3. Allergy to emulsions or opioids; 4. A history of obstructive sleep apnea dysfunction; 5. History of narcotic analgesic/sedative drug, psychotropic drug or alcohol abuse; 6. People with neuropsychiatric disorders who cannot communicate; 7. Patients with severe cardiac insufficiency, pulmonary insufficiency and other major organ dysfunction disorders.

Design outcomes

Primary

MeasureTime frame
satisfaction of patients;haemodynamics;

Secondary

MeasureTime frame
adverse reaction of digestive endoscopy;

Countries

China

Contacts

Public ContactTang Lili

The First Affiliated Hospital of Anhui Medical Univercity

tanglilys@163.com+86 18654110160

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026